Luoxin Health Technology Development (Beijing) Co., Ltd. signed the capital increase and share transfer agreement that it will raise CNY 5.7 million in an equity round of funding on October 13, 2023. The transaction will include participation from returning investor Luoxin Pharmaceuticals Group Stock Co., Ltd. The transaction has been approved by the 6th session of the company?s 5th directorate and the 5th session of the company?s 5th supervisory board. Luoxin Pharmaceuticals Group Stock Co., Ltd. stake will increase from 51% to 71.16%.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.74 CNY | -0.84% | +2.82% | -11.57% |
1st Jan change | Capi. | |
---|---|---|
-11.57% | 719M | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- 002793 Stock
- News Luoxin Pharmaceuticals Group Stock Co., Ltd.
- Luoxin Health Technology Development Co., Ltd. announced that it expects to receive CNY 5.7 million in funding from Luoxin Pharmaceuticals Group Stock Co., Ltd.